Therefore, the present research aimed to measure the levels of PR and ER in endometriotic lesions and determine a cut-off point for selecting the appropriate treatment based on the hormone receptors of these lesions to help improve the quality of life in patients with endometriosis. This evidence concerns the gene ESR1 and endometriosis.